Hospira—Carpuject Syringes Containing Morphine Sulfate for Injection: May Contain Greater-than-Intended Fill Volume
April 25, 2012 | Risk Management News
ECRI Institute’s complete weekly summary of medical device hazard and recall information is available in ECRI Institute’s Health Devices Alerts(HDA). For more information about HDA, contact us at firstname.lastname@example.org.
In an April 17, 2012, Press Release posted by FDA and in an April 18, 2012, Urgent Drug Recall letter, Hospira states that it has received reports of the syringes below containing a greater-than-intended fill level of morphine sulfate, potentially leading to patient overdose. Morphine overdose may cause respiratory depression (slowed or suspended breathing) and low blood...